85 related articles for article (PubMed ID: 27439875)
1. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation.
Kang JA; Park SH; Jeong SP; Han MH; Lee CR; Lee KM; Kim N; Song MR; Choi M; Ye M; Jung G; Lee WW; Eom SH; Park CS; Park SG
Proc Natl Acad Sci U S A; 2016 Aug; 113(31):8771-6. PubMed ID: 27439875
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of telmisartan on culture and proliferation of and Kv1.3 potassium channel expression in peripheral blood CD4+ T lymphocytes from Xinjiang Kazakh patients with hypertension.
Huang SS; Zhang QB; Yuan QY; He SL; Zhang YM
J Renin Angiotensin Aldosterone Syst; 2016 Oct; 17(4):. PubMed ID: 27765883
[TBL] [Abstract][Full Text] [Related]
3. Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes.
Ren YR; Pan F; Parvez S; Fleig A; Chong CR; Xu J; Dang Y; Zhang J; Jiang H; Penner R; Liu JO
PLoS One; 2008; 3(12):e4009. PubMed ID: 19104661
[TBL] [Abstract][Full Text] [Related]
4. Expression of the ether-a-gò-gò-related gene 1 channel during B and T lymphocyte development: role in BCR and TCR signaling.
Sala C; Staderini M; Lottini T; Duranti C; Angelini G; Constantin G; Arcangeli A
Front Immunol; 2023; 14():1111471. PubMed ID: 37744334
[TBL] [Abstract][Full Text] [Related]
5. Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators.
Selvakumar P; Fernández-Mariño AI; Khanra N; He C; Paquette AJ; Wang B; Huang R; Smider VV; Rice WJ; Swartz KJ; Meyerson JR
Nat Commun; 2022 Jul; 13(1):3854. PubMed ID: 35788586
[TBL] [Abstract][Full Text] [Related]
6. The ion channel network in T lymphocytes, a target for immunotherapy.
Conforti L
Clin Immunol; 2012 Feb; 142(2):105-6. PubMed ID: 22189042
[No Abstract] [Full Text] [Related]
7. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome.
Hu T; Buus TB; Krejsgaard T; Nansen A; Lundholt BK; Spee P; Fredholm S; Petersen DL; Blümel E; Gluud M; Monteiro MN; Willerslev-Olsen A; Andersen MH; Straten PT; Met Ö; Stolearenco V; Fogh H; Gniadecki R; Nastasi C; Litman T; Woetmann A; Gjerdrum LMR; Ødum N
Oncotarget; 2019 Aug; 10(47):4894-4906. PubMed ID: 31448055
[TBL] [Abstract][Full Text] [Related]
8. Newly Identified
Glasscock E
Epilepsy Curr; 2024; 24(3):200-202. PubMed ID: 38898907
[No Abstract] [Full Text] [Related]
9. Cereblon negatively regulates TLR4 signaling through the attenuation of ubiquitination of TRAF6.
Min Y; Wi SM; Kang JA; Yang T; Park CS; Park SG; Chung S; Shim JH; Chun E; Lee KY
Cell Death Dis; 2016 Jul; 7(7):e2313. PubMed ID: 27468689
[TBL] [Abstract][Full Text] [Related]
10. Ionic immune suppression within the tumour microenvironment limits T cell effector function.
Eil R; Vodnala SK; Clever D; Klebanoff CA; Sukumar M; Pan JH; Palmer DC; Gros A; Yamamoto TN; Patel SJ; Guittard GC; Yu Z; Carbonaro V; Okkenhaug K; Schrump DS; Linehan WM; Roychoudhuri R; Restifo NP
Nature; 2016 Sep; 537(7621):539-543. PubMed ID: 27626381
[TBL] [Abstract][Full Text] [Related]
11. Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant.
Wang RE; Wang Y; Zhang Y; Gabrelow C; Zhang Y; Chi V; Fu Q; Luo X; Wang D; Joseph S; Johnson K; Chatterjee AK; Wright TM; Nguyen-Tran VT; Teijaro J; Theofilopoulos AN; Schultz PG; Wang F
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11501-11506. PubMed ID: 27663736
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the Kv1.3 K+ Channel Enhances BCG Vaccine Efficacy by Expanding Central Memory T Lymphocytes.
Singh DK; Dwivedi VP; Ranganathan A; Bishai WR; Van Kaer L; Das G
J Infect Dis; 2016 Nov; 214(9):1456-1464. PubMed ID: 27571906
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma cells' capacity to decompose H
Sebastian S; Zhu YX; Braggio E; Shi CX; Panchabhai SC; Van Wier SA; Ahmann GJ; Chesi M; Bergsagel PL; Stewart AK; Fonseca R
Blood; 2017 Feb; 129(8):991-1007. PubMed ID: 28028022
[TBL] [Abstract][Full Text] [Related]
14. In silico analysis of enantioselective binding of immunomodulatory imide drugs to cereblon.
Murai T; Kawashita N; Tian YS; Takagi T
Springerplus; 2016; 5(1):1122. PubMed ID: 27478739
[TBL] [Abstract][Full Text] [Related]
15. Decrease of a Current Mediated by Kv1.3 Channels Causes Striatal Cholinergic Interneuron Hyperexcitability in Experimental Parkinsonism.
Tubert C; Taravini IRE; Flores-Barrera E; Sánchez GM; Prost MA; Avale ME; Tseng KY; Rela L; Murer MG
Cell Rep; 2016 Sep; 16(10):2749-2762. PubMed ID: 27568555
[TBL] [Abstract][Full Text] [Related]
16. Cereblon and its downstream substrates as molecular targets of immunomodulatory drugs.
Ito T; Handa H
Int J Hematol; 2016 Sep; 104(3):293-9. PubMed ID: 27460676
[TBL] [Abstract][Full Text] [Related]
17. Genomic and in silico analyses of CRBN gene and thalidomide embryopathy in humans.
Vianna FS; Kowalski TW; Tovo-Rodrigues L; Tagliani-Ribeiro A; Godoy BA; Fraga LR; Sanseverino MT; Hutz MH; Schuler-Faccini L
Reprod Toxicol; 2016 Dec; 66():99-106. PubMed ID: 27751757
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma.
Bila J; Sretenovic A; Jelicic J; Tosic N; Glumac I; Fekete MD; Antic D; Balint MT; Markovic O; Milojevic Z; Radojkovic M; Trajkovic G; Puric M; Pavlovic S; Mihaljevic B
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):610-615. PubMed ID: 27618360
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia.
Ward R; Li W; Abdul Y; Jackson L; Dong G; Jamil S; Filosa J; Fagan SC; Ergul A
Pharmacol Res; 2019 Apr; 142():237-250. PubMed ID: 30818045
[TBL] [Abstract][Full Text] [Related]
20. CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memory.
Song T; Liang S; Liu J; Zhang T; Yin Y; Geng C; Gao S; Feng Y; Xu H; Guo D; Roberts A; Gu Y; Cang Y
PLoS Genet; 2018 Jan; 14(1):e1007165. PubMed ID: 29370161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
